Center Studies
Study of Tamoxifen And Raloxifen (STAR) Breast Cancer Prevention Trial
Program Coordinator: Ann Kelminski, RN

Back to Center Studies

The Study of Tamoxifen and Raloxifene, or STAR, was closed to accrual on October 29, 2004.

Initial results were reported in April 2006.

Follow-up is on-going.

For inquiries, please call (808) 586-2979.

Back to Center Studies